Non-interventional retrospective study to evaluate menstrual bleeding profiles, tolerability and quality of life of women using the new vaginal ring Ornibel® delivering etonogestrel 0.120 mg and ethinylestradiol (EE) 0.015 mg per day
Research Square (Research Square)